73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Not all patients want faster cancer drug approvals without certainty they work

Not all patients want faster cancer drug approvals without certainty they work

byLondon School of EconomicsCredit: Pixabay/CC0 Public DomainPatients with cancer could be willing to wait for greater certainty of the benefit of new cancer drugs before they are approved by th

Not all patients want faster cancer drug approvals without certainty they work

byLondon School of EconomicsCredit: Pixabay/CC0 Public DomainPatients with cancer could be willing to wait for greater certainty of the benefit of new cancer drugs before they are approved by th
Experts assess promise of vamorolone to treat Duchenne muscular dystrophy

Experts assess promise of vamorolone to treat Duchenne muscular dystrophy

by IOS PressSkeletal muscle fibers. Credit: Berkshire Community College Bioscience Image Library / Public domainThe drug vamorolone (Agamree) has been hailed as a promising new drug to treat Duch

Experts assess promise of vamorolone to treat Duchenne muscular dystrophy

by IOS PressSkeletal muscle fibers. Credit: Berkshire Community College Bioscience Image Library / Public domainThe drug vamorolone (Agamree) has been hailed as a promising new drug to treat Duch
Quantitative pathologic analysis may help predict prognosis in colorectal cancer

Quantitative pathologic analysis may help predict prognosis in colorectal cancer

The quantitative segmentation algorithm (QuantCRC) may improve the prediction of prognosis in colorectal cancer (CRC), according to a study published online Aug. 16 inGastroenterology.Reetesh K.

Quantitative pathologic analysis may help predict prognosis in colorectal cancer

The quantitative segmentation algorithm (QuantCRC) may improve the prediction of prognosis in colorectal cancer (CRC), according to a study published online Aug. 16 inGastroenterology.Reetesh K.
Barriers to early clinical trial access for adolescents and young adults still exist

Barriers to early clinical trial access for adolescents and young adults still exist

byEuropean Society for Medical OncologyYoung cancer patients at the crossroads of childhood and adulthood seem to be stuck in a treatment impasse. A study to be presented at the ESMO 2018 Congre

Barriers to early clinical trial access for adolescents and young adults still exist

byEuropean Society for Medical OncologyYoung cancer patients at the crossroads of childhood and adulthood seem to be stuck in a treatment impasse. A study to be presented at the ESMO 2018 Congre
Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainA Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment wi

Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainA Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment wi
New study reveals how epithelial cells in the body naturally eliminate 'precancerous' ones

New study reveals how epithelial cells in the body naturally eliminate 'precancerous' ones

by Waseda UniversityWaseda University researchers identify the underlying mechanism behind the extrusion of precancerous cells by epithelial cells, a mechanism that prevents the formation of canc

New study reveals how epithelial cells in the body naturally eliminate 'precancerous' ones

by Waseda UniversityWaseda University researchers identify the underlying mechanism behind the extrusion of precancerous cells by epithelial cells, a mechanism that prevents the formation of canc
Development and application of competing risks and multi-state models in cancer epidemiology

Development and application of competing risks and multi-state models in cancer epidemiology

byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainCompeting risks and multi-state models allow us to study complex disease settings and answer composite research questions and should be u

Development and application of competing risks and multi-state models in cancer epidemiology

byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainCompeting risks and multi-state models allow us to study complex disease settings and answer composite research questions and should be u
Discovery unveils promising anticancer drug targeting KRAS protein

Discovery unveils promising anticancer drug targeting KRAS protein

byVirginia Commonwealth UniversityKRB-456 inhibits the growth in vivo of orthotopic mt KRAS tumors derived from pancreatic cancer patients. Tumor biopsies from pancreatic cancer patient G160 wer

Discovery unveils promising anticancer drug targeting KRAS protein

byVirginia Commonwealth UniversityKRB-456 inhibits the growth in vivo of orthotopic mt KRAS tumors derived from pancreatic cancer patients. Tumor biopsies from pancreatic cancer patient G160 wer
Genomic assay may predict long-term prognosis in premenopausal patients with HR-positive early-stage breast cancer

Genomic assay may predict long-term prognosis in premenopausal patients with HR-positive early-stage breast cancer

byAmerican Association for Cancer ResearchThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in

Genomic assay may predict long-term prognosis in premenopausal patients with HR-positive early-stage breast cancer

byAmerican Association for Cancer ResearchThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in
Colon cancer is being spotted in younger people, and at later stages

Colon cancer is being spotted in younger people, and at later stages

by Steven ReinbergColon cancer continues to rise among younger U.S. adults, with the American Cancer Society reporting a doubling of cases in people younger than 55 in about 25 years.Also, significant

Colon cancer is being spotted in younger people, and at later stages

by Steven ReinbergColon cancer continues to rise among younger U.S. adults, with the American Cancer Society reporting a doubling of cases in people younger than 55 in about 25 years.Also, significant
Colonoscopy is the most comprehensive screening for colorectal cancer, despite flawed interpretations of a new study

Colonoscopy is the most comprehensive screening for colorectal cancer, despite flawed interpretations of a new study

by Franklin G. Berger,The ConversationCredit: American College of GastroenterologyA recently published study in a high-profile medical journal appeared to call into questionthe efficacy of

Colonoscopy is the most comprehensive screening for colorectal cancer, despite flawed interpretations of a new study

by Franklin G. Berger,The ConversationCredit: American College of GastroenterologyA recently published study in a high-profile medical journal appeared to call into questionthe efficacy of